tg-2-in-1

TG-2-IN-1 is a potent transglutaminase-2 (TGM-2) inhibitor.TG-2-IN-1 is used in the study of cancer, neurological disorders, and immune system disorders.

TG-2-IN-4 (compound 8), an inhibitor of transglutaminase 2 (TG2) with an IC 50 value of less than 0.5 mM, is utilized in the study of inflammatory disorders [1].

1. Dehydroabietic acid (Dehydroabietate) (DAA) is an EBV-EA activation inhibitor. 2. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. 3. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.

Tridocosahexaenoylglycerol (TG-DHA), an orally active dietary supplement, enhances outcomes in autoimmune encephalomyelitis among mice, exhibits beneficial impacts on neurodegenerative conditions, and fosters macular function improvement in diabetic retinopathy. It is applicable for investigating neurological, inflammatory immune, and metabolic diseases [1] [2] [3].

1-Palmitoyl-2-10-oahsa-3-oleoyl-sn-glycerol (16:0-10-Oahsa-18:1-TG) is a compound that includes OAHSA, utilized in adipose tissue research.

1-Palmitoyl-2-12-oahsa-3-oleoyl-sn-glycerol (16:0-12-Oahsa-18:1-TG) is a compound containing OAHSA, utilized in adipose tissue research.